Goodwill
McKesson Goodwill decreased by 0.1% to $11.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.9%, from $10.02B to $11.32B. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 3.6% CAGR.
Analysis
How to read this metric
A stable or increasing balance suggests successful acquisitions, while a significant decrease often signals an impairment charge due to poor performance of acquired units.
Detailed definition
This is an intangible asset that arises when a company acquires another entity for a price higher than the fair market v...
Peer comparison
Large-cap companies in the healthcare sector often carry significant goodwill due to frequent M&A activity to consolidate market share.
goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.52B | $9.47B | $9.46B | $9.45B | $9.37B | $9.24B | $9.93B | $9.95B | $9.97B | $9.93B | $9.97B | $10.13B | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| QoQ Change | — | -0.5% | -0.1% | -0.1% | -0.9% | -1.4% | +7.5% | +0.1% | +0.2% | -0.4% | +0.4% | +1.6% | -0.1% | -0.3% | -0.8% | +0.2% | +13.4% | -0.7% | +0.4% | -0.1% |
| YoY Change | — | — | — | — | -1.6% | -2.5% | +5.0% | +5.2% | +6.4% | +7.5% | +0.4% | +1.9% | +1.5% | +1.5% | +0.3% | -1.1% | +12.3% | +11.9% | +13.2% | +12.9% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Corporate | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| International | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| Medical-Surgical Solutions | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| North American Pharmaceutical | — | — | — | — | — | $11.28B | $11.32B | $11.32B |
| Oncology & Multispecialty | — | — | — | — | — | $11.28B | $11.32B | $11.32B |
| Prescription Technology Solutions | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| U.S. Pharmaceutical | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
| Total | $10.12B | $10.09B | $10B | $10.02B | $11.37B | $11.28B | $11.32B | $11.32B |
Corporate, International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Goodwill at Other Companies
Frequently Asked Questions
- What is McKesson's goodwill?
- McKesson (MCK) reported goodwill of $11.32B in Q1 2026.
- How has McKesson's goodwill changed year-over-year?
- McKesson's goodwill increased by 12.9% year-over-year, from $10.02B to $11.32B.
- What is the long-term trend for McKesson's goodwill?
- Over 5 years (2020 to 2025), McKesson's goodwill has grown at a 3.6% compound annual growth rate (CAGR), from $9.51B to $11.32B.
- What does goodwill mean?
- The premium paid over the fair value of assets when acquiring another company.